BioMérieux

bioMérieux
Société Anonyme
Traded as Euronext: BIM
Founded 1963 (1963)
Founder Alain Mérieux
Headquarters Marcy-l'Étoile, France
Area served
Worldwide
Key people
Jean-Luc Bélingard
(CEO)
Alexandre Mérieux
(Chairman)
Marcel Mérieux, Charles Mérieux
Revenue 1,698 M€ (2014) [1] Increase +7 % vs 2013
Number of employees
8 935
Slogan Pioneering diagnostics
Website www.biomerieux.com

bioMérieux (Euronext: BIM) is a multinational biotechnology company founded and headquartered in France. A world leader in the field of in vitro diagnostics for 50 years, bioMérieux is present in more than 150 countries through 42 subsidiaries and a large network of distributors.

bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the NYSE Euronext Paris stock exchange (BIM – ISIN: FR0010096479).

Revenue

bioMérieux has revenues of €1.698 billion as of 2014 with 88% of sales occurring outside France.

History

References

External links

This article is issued from Wikipedia - version of the Tuesday, April 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.